Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age
Clinical trial NCT05882357 · COMPLETED
Trial details
- NCT number
- NCT05882357
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2025-09-04
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.